A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

NCT05691478 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

1122

Enrollment

NIH

Sponsor class

Conditions

High Grade Osteosarcoma
Localized Osteosarcoma
Metastatic Osteosarcoma
Secondary Osteosarcoma

Interventions

PROCEDURE: Bone Scan
DRUG: Cabozantinib S-malate
DRUG: Cisplatin
PROCEDURE: Computed Tomography
DRUG: Doxorubicin Hydrochloride
PROCEDURE: Magnetic Resonance Imaging
DRUG: Methotrexate
PROCEDURE: Surgical Procedure
PROCEDURE: X-Ray Imaging

Sponsor

National Cancer Institute (NCI)